Mondido, John Cleve .
HRN: 24-02-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2025
CEFUROXIME 750MG (VIAL)
02/16/2025
02/23/2025
IV
450mg
Q8h
Dengue Fever With WS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes